ROJA RANI BUDHA

@hkcp.edu.in

Assistant Professor, Department of Pharmacology
H. K. College of Pharmacy

ROJA RANI BUDHA


               Download Compact PDF  
https://researchid.co/rojarani
Ph.D from Sri Padmavati Mahila Visvavidyalayam;
M.Pharm Pharmacology from Annamalai University;
B.Pharm from Acharya Nagarjuna University

EDUCATION

M.Pharm, Ph.D.

RESEARCH, TEACHING, or OTHER INTERESTS

Pharmacology, Toxicology and Pharmaceutics, General Pharmacology, Toxicology and Pharmaceutics, Pharmacology, Pharmaceutical Science
32

Scopus Publications

114

Scholar Citations

6

Scholar h-index

2

Scholar i10-index

Scopus Publications

  • Comparative analysis of Mpox clades: epidemiology, transmission dynamics, and detection strategies
    Shriyansh Srivastava, Dheeraj Sharma, Sathvik Belagodu Sridhar, Sachin Kumar, G. S. N. Koteswara Rao, Roja Rani Budha, Molakpogu Ravindra Babu, Rakesh Sahu, Sanjit Sah, Rachana Mehta, Nahun Alejandro Giraldo-Corrales, Jack Feehan, Vasso Apostolopoulos, Alfonso J. Rodriguez-Morales
    BMC Infectious Diseases, 2025
    BACKGROUND: Monkeypox (Mpox), a zoonotic disease caused by the monkeypox virus, has gained global attention due to rising incidence and the emergence of new clades. Understanding the epidemiology, transmission dynamics, and diagnostic challenges associated with the two major clades, Clades I and II, is crucial for outbreak preparedness and control. METHODS: This review analyzes Mpox clades, highlighting their geographic distribution, virulence, transmissibility, and diagnostic approaches. It also presents recent outbreaks, diagnostic advancements, vaccination strategies, and critical research gaps in Mpox surveillance and response. RESULTS: Clade I, primarily in Central Africa, exhibits the highest virulence with a 5–10% case fatality rate. Clade II, which includes subclades IIa, IIb, and the newly identified Clade Ib, demonstrates lower virulence but higher transmissibility beyond endemic regions. Recent outbreaks (2022–2024), driven by Clade IIb, present atypical clinical presentations and emphasize intimate human-to-human contact as a key transmission route. Polymerase chain reaction, next-generation sequencing, and emerging CRISPR-based diagnostics have improved detection, while modified vaccinia Ankara-based vaccines have shown effectiveness despite challenges in equitable distribution. CONCLUSIONS: Addressing critical research gaps, such as clade-specific virulence mechanisms, zoonotic reservoirs, and evolutionary patterns, is essential for improving Mpox surveillance and control. Strengthening genomic surveillance, expanding access to affordable diagnostics, and fostering international collaboration will enhance preparedness for future outbreaks and mitigate the impact of this emerging infectious disease. HIGHLIGHTS: • Comparison of Mpox virus (MPXV) clades, in geography, virulence, transmission, and clinical outcomes between Clade I, Clade II, and emerging subclades IIb and Ib. • The epidemiology of Mpox focuses on the 2022–2024 global outbreaks of Clade IIb, marked by unusual clinical presentations and fast human-to-human spread in non-endemic areas. • Key advancements in diagnostic technologies like PCR, NGS, and CRISPR assays, improving MPXV detection and clade differentiation. • The effectiveness of MVA-based vaccines against various MPXV clades is presented while highlighting challenges in equitable distribution and region-specific vaccination strategies. • Emerging Mpox research priorities include genomic surveillance, clade-specific virulence, affordable diagnostics, and overcoming socioeconomic barriers to outbreak management.
  • Genistein and Gastrointestinal Cancers: A Comprehensive Review of Recent Studies and Future Outlook
    Rohit Yennawar, Nosheen Abjani, Neel Parekh, Roja Rani Budha, Ginpreet Kaur, Hemant Joshi, Seema Ramniwas, Harvinder Popli, Shafiul Haque, Darin Mansor Mathkor, Hardeep Singh Tuli
    Journal of Biochemical and Molecular Toxicology, 2025
    Cancer is a global disease that causes millions of deaths annually, with gastrointestinal cancers becoming more prevalent than lung and breast cancers. Lifestyle factors like smoking and unhealthy eating habits increase the risk of cancer. Precision medicine approaches are needed to improve patient outcomes and cancer survival rates. Genistein, a natural isoflavonoid, acts as an anticancer medication by inducing apoptosis, preventing metastasis, and triggering cell death. It relies on various signaling pathways, including JAK1/2‐STAT3, AKT/MDM2, EGFR, MEK/ERK, Shh‐Gli1, MMP‐2, FLT4, STAT3, PLK‐1, and others. Elevated serum concentrations of isoflavones like genistein and daidzein have been linked to a decreased incidence of stomach cancer. Consumption of genistein through diet has been linked to potential health benefits, such as heart disease prevention, gastrointestinal, prostate, and breast cancer prevention through chemotherapy, and alleviation of postmenopausal symptoms. Genistein is a potent anticancer medication that works against various cancer types. This review examines the pharmacokinetics, chemistry, and possible applications of genistein in the treatment of pancreatic, esophageal, gastric, liver, and colorectal malignancies. The utilization of nanotechnology in conjunction with genistein is also discussed.
  • Bionanocomposites in Nasal Drug Delivery
    RajaSekhar Reddy Alavala, S. N. Koteswara Rao Gudhanti, Sree Harsha Nagaraja, Diya Karbhari, Roja Rani Budha, Khushwant S. Yadav
    Bionanocomposites for Biomedical Applications Fundamental Concepts Impacts and Clinical Applications, 2025
    Bionanocomposites have recently gained attention because of their enhanced physicochemical characteristics, which are more beneficial in the biomedical sector. When drugs are delivered using targeted nanocomposites, the negative effects of highly specific drugs are avoided, and a controlled release rate is ensured at the intended site. Combining two or more components to create a single material with special qualities, including high loading capacity, increased mechanical capabilities, reduced toxicity, improved biocompatibility and biodegradability, and the ability to image guidance are the special characteristics of the bionanocomposites. The current book chapter deals with the different synthetic approaches of nanocomposites by using biopolymers from various sources. The major focus of the applications of the nanocomposites was given to nasal drug delivery for treating various diseases with suitable examples. There was in-depth information, and analysis was provided to understand the nasal route as the drug delivery site for various categories of drugs. The current research and its contribution to promoting the use of nanocomposites as nasal drug delivery systems were discussed in detail.
  • Rising burden of human metapneumovirus: A call for global preparedness
    Shriyansh Srivastava, Dheeraj Sharma, Sathvik Belagodu Sridhar, Sachin Kumar, G.S.N. Koteswara Rao, Roja Rani Budha, Rachana Mehta, Aroop Mohanty, Sanjit Sah
    Clinical Infection in Practice, 2025
  • Exploration of green catalytic Hantzsch process for synthesis of polyhydroquinoline derivatives and their in silico & in vitro evaluation as anti-tubercular agents
    Tulshidas S Savale, Nachiket Joshi, SN Koteswara Rao G, Savita M. Mathure, Santosh S. Chobe, Rahul A. More, Roja Rani Budha, Rajasekhar Reddy Alavala
    Journal of Molecular Structure, 2025
  • Metallic Biomaterials for Pharmaceutical and Biomedical Applications
    Metals in Medicine Volume 1 Metals for Tissue Engineering and Pharmaceutical Applications, 2025
  • Utilization of Palladium in Photothermal Therapy of Cancer
    Metals in Medicine Volume 2 Metallic Nanoparticles for Biomedical Applications, 2025
  • Metallic Foams for Biomedical Application
    Metals in Medicine Volume 1 Metals for Tissue Engineering and Pharmaceutical Applications, 2025
  • Modern Computational Intelligence Based Drug Repurposing for Cancer
    Roja Rani Budha, Nikhat Khan, Saba Wahid A. M. Khan, Esha S. Attar, S. N. Koteswara Rao G.
    Applications of Computational Tools in Drug Design and Development, 2025
  • Protein Binding Prediction by Computational Methods
    Ritam Mondal, Deepika Paliwal, Aman Thakur, Rakesh Sahu, Roja Rani Budha
    Applications of Computational Tools in Drug Design and Development, 2025
  • Computational Modelling of Pharmaceutical Die Filling Processes
    Naseeb Basha Shaik, Roja Rani Budha, Bikash Rajan Jena, Rajasekhar Reddy Alavala, S. N. Koteswara Rao G.
    Applications of Computational Tools in Drug Design and Development, 2025
  • Pediatric Diffuse High-Grade Gliomas: A Comprehensive Review Of Advanced Methods Of Diagnosis And Treatment
    Roja Rani Budha, Saba Wahid Khan, Deep Chandraprakash Sharma, Yash Kulchandani, Koteswara Rao GSN
    Current Cancer Drug Targets, 2025
  • Diagnostic and Surgical Uses of Explainable AI (XAI)
    Roja Rani Budha, Saba Wahid A.M. Khan, Tushar Lokhande, G.S.N. Koteswara Rao, Shams Aaghaz
    Explainable and Responsible Artificial Intelligence in Healthcare, 2025
  • Advances in the Computational Prediction of Absorption Prediction of Pharmaceuticals
    Saba Wahid A. M. Khan, Aditi Pandey, Somesh Mishra, Roja Rani Budha, S. N. Koteswara Rao G.
    Applications of Computational Tools in Drug Design and Development, 2025
  • Revolutionizing Cancer Treatment: Harnessing Cell-membrane Coated Nanoparticles for Precise Targeting and Therapy
    Pranali Waghode, G.S.N. Koteswara Rao, Sanika Deshpande, Roja Rani Budha, Rajasekhar Reddy Alavala, Surya Kovvasu
    Current Cancer Therapy Reviews, 2025
  • Computational Modelling for Formulation Design
    Teja Kumar Ponduri, Roja Rani Budha, Deepika Paliwal, Kartheek Siripurapu, Rajasekhar Reddy Alavala, S. N. Koteswara Rao G.
    Applications of Computational Tools in Drug Design and Development, 2025
  • Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19-PIMS-grade 3: A Case Report
    G Lakshmi Narasimha, D Girirajasekhar, Prakash Goudanavar, Roja Rani Budha, G.S.N. KoteswaraRao, Buduru Gowthami, N. Raghavendra Naveen
    Coronaviruses, 2025
  • Autonomous Robots: A Disruptive Technology in the Health Sector
    Creating Smart Healthcare with Blockchain and Advanced Digital Technology, 2025
  • Inhalation Aerosol Based Targeted Drug Delivery to Upper Airways: Computational Fluid Dynamics (CFD) Approach
    Bikash Rajan Jena, Soumyashree Tripathy, Surya Kanta Swain, Roja Rani Budha, Naseeb Basha Shaik, Rajasekhar Reddy Alavala, S. N. Koteswara Rao G., Amiya Prusty, Prasanna Parida
    Applications of Computational Tools in Drug Design and Development, 2025
  • Targeting H3N2 influenza: advancements in treatment and vaccine strategies
    Shriyansh Srivastava, Nandani Jayaswal, Sachin Kumar, G. S. N. Koteswara Rao, Roja Rani Budha, Aroop Mohanty, Rachana Mehta, Vasso Apostolopoulos, Sanjit Sah, D. Katterine Bonilla-Aldana, Ricardo Ulloque-Badaracco, Alfonso J. Rodriguez-Morales
    Expert Review of Anti Infective Therapy, 2025
  • Radiopharmaceuticals: A New Vista for Diagnosis and Treatment of Thyroid Cancer
    Siddhi Vernekar, Roja Rani Budha, Rajasekhar Reddy Alavala
    Current Radiopharmaceuticals, 2024
  • Exploring Nano-Based Therapeutics by Quantum Computational Modeling
    Ponduri Teja Kumar, Roja Rani Budha, G. Raghavendra Kumar, B. Nagamani, G.S.N. Koteswara Rao
    Drug Delivery Systems Using Quantum Computing, 2024
  • Quantum Computational Methods and Computer-Aided Drug Design in Transdermal Drug Delivery of Nanoparticles
    Jahasultana Mohammed, Haritha Lanka, Roja Rani Budha, Rajasekhar Reddy Alavala, G.S.N. Koteswara Rao, Surya Kovvasu
    Drug Delivery Systems Using Quantum Computing, 2024
  • Matrix formers
    Prince Kumar, G.S.N. Koteswara Rao, Rajasekhar Reddy Alavala, Roja Rani Budha, Pappala Appala Naidu, Khushwant S. Yadav
    Polymers for Oral Drug Delivery Technologies, 2024
  • Functional polymeric coatings for immediate release dosage forms
    Pappala Appala Naidu, G.S.N. Koteswara Rao, Rajasekhar Reddy Alavala, Roja Rani Budha, Prince Kumar, Khushwant S. Yadav
    Polymers for Oral Drug Delivery Technologies, 2024
  • Patient monitoring using blockchain
    Pharmaceutical Industry 4 0 Future Challenges Application, 2023
  • Development, characterization and optimization of solid lipid nanoparticles of alpha-mangostin by central composite design approach
    Vutti Nagendra Babu, Gudhanti S. N. Koteswara Rao, Roja Rani Budha, Rajasekhar Reddy Alavala, Prasanna Kumar Desu, Govada Kishore Babu, Arja Durga Prasad
    Journal of Applied Pharmaceutical Science, 2023
  • Quantum dots in diagnostic imaging
    GSN Koteswara Rao, Rajasekhar Reddy Alavala, Praveen Sivadasu, Roja Rani Budha, Khushwant S. Yadav
    Green Sustainable Process for Chemical and Environmental Engineering and Science Recent Advances in Nanocarriers, 2023
  • Additives screening for the formulation of solid lipid nanoparticles of alpha-mangostin
    Nagendra Babu VUTTI, SN Koteswara Rao GUDHANTI, Rajasekhar Reddy ALAVALA, Prasanna Kumar DESU, Roja Rani BUDHA, Kishore Babu GOVADA, Durga Prasad ARJA, Nagendra CH
    Journal of Research in Pharmacy, 2023
  • Influence of Eugenol on the Pharmacokinetics and Pharmacodynamics of Gliclazide in rabbits
    Roja Rani Budha, Santhrani Thaakur, GSN Koteswara Rao, Lavanya Yaidikar, M. Sathish Kumar, Ravi Manne
    Research Journal of Pharmacy and Technology, 2022
  • Compression-coated pulsatile chronomodulated therapeutic system: QbD assisted optimization
    Hibah M. Aldawsari, N. Raghavendra Naveen, Nabil A. Alhakamy, Prakash S. Goudanavar, GSN Koteswara Rao, Roja Rani Budha, Anroop B. Nair, Shaimaa M. Badr-Eldin
    Drug Delivery, 2022
  • Prospective study of irrational prescribing in an Indian tertiary care hospital: Omission of prescription and inappropriate prescription in a multidisciplinary unit
    B. Y. Kumar, G. Chakravarthi, G.S.N. K. Rao, A. R. Reddy, K. K. Naidu, K. Umasankar
    Indian Journal of Pharmaceutical Sciences, 2021

RECENT SCHOLAR PUBLICATIONS

  • Bionanocomposites in Nasal Drug Delivery
    RSR Alavala, SNKR Gudhanti, SH Nagaraja, D Karbhari, RR Budha, ...
    Bionanocomposites for Biomedical Applications, 176-199 , 2026
    2026
    Citations: 1
  • Comparative analysis of Mpox clades: epidemiology, transmission dynamics, and detection strategies
    S Srivastava, D Sharma, SB Sridhar, S Kumar, GSNK Rao, RR Budha, ...
    BMC infectious diseases 25 (1), 1290 , 2025
    2025
    Citations: 11
  • Modern Computational Intelligence Based Drug Repurposing for Cancer
    RR Budha, N Khan, SWAM Khan, ES Attar, SNK Rao G
    Applications of Computational Tools in Drug Design and Development, 859-884 , 2025
    2025
  • Advances in the Computational Prediction of Absorption Prediction of Pharmaceuticals
    SWAM Khan, A Pandey, S Mishra, RR Budha, SNKR G
    Applications of Computational Tools in Drug Design and Development, 387-425 , 2025
    2025
    Citations: 1
  • Computational modelling of pharmaceutical die filling processes
    NB Shaik, RR Budha, BR Jena, RR Alavala, SNK Rao G
    Applications of computational tools in drug design and development, 199-243 , 2025
    2025
    Citations: 1
  • Protein Binding Prediction by Computational Methods
    R Mondal, D Paliwal, A Thakur, R Sahu, RR Budha
    Applications of Computational Tools in Drug Design and Development, 427-473 , 2025
    2025
    Citations: 2
  • Computational Modelling for Formulation Design
    TK Ponduri, RR Budha, D Paliwal, K Siripurapu, RR Alavala, SNK Rao G
    Applications of Computational Tools in Drug Design and Development, 55-98 , 2025
    2025
    Citations: 4
  • Inhalation Aerosol Based Targeted Drug Delivery to Upper Airways: Computational Fluid Dynamics (CFD) Approach
    BR Jena, S Tripathy, SK Swain, RR Budha, NB Shaik, RR Alavala, ...
    Applications of Computational Tools in Drug Design and Development, 245-277 , 2025
    2025
    Citations: 1
  • Revolutionizing Cancer Treatment: Harnessing Cell-membrane Coated Nanoparticles for Precise Targeting and Therapy
    P Waghode, GSNK Rao, S Deshpande, RR Budha, RR Alavala, ...
    Current Cancer Therapy Reviews 21 (3), 373-389 , 2025
    2025
    Citations: 1
  • Rising burden of human metapneumovirus: A call for global preparedness
    S Srivastava, D Sharma, SB Sridhar, S Kumar, GSNK Rao, RR Budha, ...
    Clinical Infection in Practice 26, 100416 , 2025
    2025
  • Diagnostic and Surgical Uses of Explainable AI (XAI)
    RR Budha, SWAM Khan, T Lokhande, GSNK Rao, S Aaghaz
    Explainable and Responsible Artificial Intelligence in Healthcare, 65-88 , 2025
    2025
    Citations: 2
  • Autonomous Robots: A Disruptive Technology in the Health Sector
    BR Jena, GSNK Rao, NJ Kothakota, RR Budha, L Srinivas, J Rajkumar, ...
    Creating Smart Healthcare with Blockchain and Advanced Digital Technology … , 2025
    2025
    Citations: 4
  • Metallic Foams for Biomedical Application
    D Yadav, GSNK Rao, RR Budha, NB Rekha
    Metals in Medicine, 85-100 , 2025
    2025
    Citations: 1
  • Utilization of Palladium in Photothermal Therapy of Cancer
    SK Konidala, BS Padya, GSNK Rao, RR Budha
    Metals in Medicine, 371-392 , 2025
    2025
  • Metallic Biomaterials for Pharmaceutical and Biomedical Applications
    S Chaudhary, RR Budha, GSNK Rao, SK Konidala
    Metals in Medicine, 41-57 , 2025
    2025
    Citations: 1
  • Exploration of green catalytic Hantzsch process for synthesis of polyhydroquinoline derivatives and their in silico & in vitro evaluation as anti-tubercular agents
    TS Savale, N Joshi, SM Mathure, SS Chobe, RA More, RR Budha, ...
    Journal of Molecular Structure 1320, 139703 , 2025
    2025
    Citations: 7
  • Targeting H3N2 influenza: Advancements in treatment and vaccine strategies
    S Srivastava, N Jayaswal, S Kumar, GSNK Rao, RR Budha, A Mohanty, ...
    Expert Review of Anti-infective Therapy 23 (1), 5-18 , 2025
    2025
    Citations: 9
  • Targeting Mpox: From Pharmacological Mechanisms to Next-Generation Therapies
    S Srivastava, R Sharma, SB Sridhar, A Mohammed, M Tariq, F Abdulhafiz, ...
    Preprints, 2025071265 , 2025
    2025
    Citations: 1
  • Pediatric Diffuse High-Grade Gliomas: A Comprehensive Review Of Advanced Methods Of Diagnosis And Treatment
    RR Budha, SWAM Khan, DC Sharma, Y Kulchandani, KR Gsn
    Current Cancer Drug Targets , 2025
    2025
    Citations: 2
  • Functional polymeric coatings for immediate release dosage forms
    PA Naidu, GSNK Rao, RR Alavala, RR Budha, P Kumar, KS Yadav
    Polymers for Oral Drug Delivery Technologies, 523-540 , 2025
    2025

MOST CITED SCHOLAR PUBLICATIONS

  • Compression-coated pulsatile chronomodulated therapeutic system: QbD assisted optimization
    HM Aldawsari, NR Naveen, NA Alhakamy, PS Goudanavar, GSNK Rao, ...
    Drug Delivery 29 (1), 2258-2268 , 2022
    2022
    Citations: 28
  • Comparative analysis of Mpox clades: epidemiology, transmission dynamics, and detection strategies
    S Srivastava, D Sharma, SB Sridhar, S Kumar, GSNK Rao, RR Budha, ...
    BMC infectious diseases 25 (1), 1290 , 2025
    2025
    Citations: 11
  • Targeting H3N2 influenza: Advancements in treatment and vaccine strategies
    S Srivastava, N Jayaswal, S Kumar, GSNK Rao, RR Budha, A Mohanty, ...
    Expert Review of Anti-infective Therapy 23 (1), 5-18 , 2025
    2025
    Citations: 9
  • Exploration of green catalytic Hantzsch process for synthesis of polyhydroquinoline derivatives and their in silico & in vitro evaluation as anti-tubercular agents
    TS Savale, N Joshi, SM Mathure, SS Chobe, RA More, RR Budha, ...
    Journal of Molecular Structure 1320, 139703 , 2025
    2025
    Citations: 7
  • Development, characterization and optimization of solid lipid nanoparticles of alpha-mangostin by central composite design approach
    VN Babu, GSNK Rao, RR Budha, RR Alavala, PK Desu, GK Babu, ...
    Journal of Applied Pharmaceutical Science 13 (8), 140-150 , 2023
    2023
    Citations: 7
  • Radiopharmaceuticals: A new vista for diagnosis and treatment of thyroid cancer
    S Vernekar, RR Budha, RR Alavala
    Current Radiopharmaceuticals 17 (2), 148-162 , 2024
    2024
    Citations: 6
  • Computational Modelling for Formulation Design
    TK Ponduri, RR Budha, D Paliwal, K Siripurapu, RR Alavala, SNK Rao G
    Applications of Computational Tools in Drug Design and Development, 55-98 , 2025
    2025
    Citations: 4
  • Autonomous Robots: A Disruptive Technology in the Health Sector
    BR Jena, GSNK Rao, NJ Kothakota, RR Budha, L Srinivas, J Rajkumar, ...
    Creating Smart Healthcare with Blockchain and Advanced Digital Technology … , 2025
    2025
    Citations: 4
  • Additives screening for the formulation of solid lipid nanoparticles of alpha-mangostin
    NB Vutti, SKR Gudhanti, RR Alavala, PK Desu, RR Budha, KB Govada, ...
    Journal of Research in Pharmacy 27 (2), 794-810 , 2023
    2023
    Citations: 4
  • Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19-PIMS-grade 3: A Case Report
    GL Narasimha, D Girirajasekhar, P Goudanavar, RR Budha, GSN, ...
    Coronaviruses , 2024
    2024
    Citations: 3
  • Multidose studies in rabbits for determining pharmacokinetic and pharmacodynamic interactions of gliclazide with nutraceutical
    RR BUDHA, S THAAKUR, GSNK RAO, L YAIDIKAR, R MANNE, ...
    International Journal of Pharmaceutical Research 13 (1) , 2021
    2021
    Citations: 3
  • Impact of climate change on soil loss in Mudhole Watershed of Telangana using GIS and RUSLE
    RS Rani, R Rejani, GM Kumar, YS Lakshmi, S DK
    Indian Journal of Dryland Agricultural Research and Development 34 (1), 47-52 , 2019
    2019
    Citations: 3
  • Protein Binding Prediction by Computational Methods
    R Mondal, D Paliwal, A Thakur, R Sahu, RR Budha
    Applications of Computational Tools in Drug Design and Development, 427-473 , 2025
    2025
    Citations: 2
  • Diagnostic and Surgical Uses of Explainable AI (XAI)
    RR Budha, SWAM Khan, T Lokhande, GSNK Rao, S Aaghaz
    Explainable and Responsible Artificial Intelligence in Healthcare, 65-88 , 2025
    2025
    Citations: 2
  • Pediatric Diffuse High-Grade Gliomas: A Comprehensive Review Of Advanced Methods Of Diagnosis And Treatment
    RR Budha, SWAM Khan, DC Sharma, Y Kulchandani, KR Gsn
    Current Cancer Drug Targets , 2025
    2025
    Citations: 2
  • Exploring Nano‐Based Therapeutics by Quantum Computational Modeling
    PT Kumar, RR Budha, GR Kumar, B Nagamani, GSNK Rao
    Drug Delivery Systems Using Quantum Computing, 93-139 , 2024
    2024
    Citations: 2
  • Quantum Computational Methods and Computer‐Aided Drug Design in Transdermal Drug Delivery of Nanoparticles
    J Mohammed, H Lanka, RR Budha, RR Alavala, GSNK Rao, S Kovvasu
    Drug Delivery Systems Using Quantum Computing, 231-246 , 2024
    2024
    Citations: 2
  • Quantum dots in diagnostic imaging
    GSNK Rao, RR Alavala, P Sivadasu, RR Budha, KS Yadav
    Green Sustainable Process for Chemical and Environmental Engineering and … , 2023
    2023
    Citations: 2
  • Bionanocomposites in Nasal Drug Delivery
    RSR Alavala, SNKR Gudhanti, SH Nagaraja, D Karbhari, RR Budha, ...
    Bionanocomposites for Biomedical Applications, 176-199 , 2026
    2026
    Citations: 1
  • Advances in the Computational Prediction of Absorption Prediction of Pharmaceuticals
    SWAM Khan, A Pandey, S Mishra, RR Budha, SNKR G
    Applications of Computational Tools in Drug Design and Development, 387-425 , 2025
    2025
    Citations: 1